Development of SARS-CoV-2 entry antivirals

Area of Science:

• Virology
• Drug Discovery
• Infectious Diseases

Background:

• The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic necessitated rapid development of effective antiviral therapies.
• Targeting viral entry mechanisms presents a promising strategy for combating SARS-CoV-2 infections.
• Understanding viral entry is crucial for designing effective therapeutic interventions.

Purpose of the Study:

• To elucidate the mechanism of SARS-CoV-2 viral entry.
• To summarize the current development of antiviral inhibitors targeting viral entry.
• To explore future directions for developing more potent SARS-CoV-2 entry inhibitors.

Main Methods:

• Literature review of scientific publications on SARS-CoV-2 entry mechanisms.
• Analysis of existing antiviral drugs and drug candidates targeting viral entry.
• Synthesis of information to identify trends and future research opportunities.

Main Results:

• Detailed explanation of the molecular mechanisms by which SARS-CoV-2 enters host cells.
• Comprehensive overview of various classes of antiviral inhibitors targeting different stages of viral entry.
• Identification of key viral and host factors involved in SARS-CoV-2 entry.

Conclusions:

• Antivirals targeting viral entry are essential for controlling the SARS-CoV-2 pandemic.
• Further research into novel inhibitors could lead to more potent and broad-spectrum anti-coronavirus drugs.
• This review provides insights for the discovery of candidate drugs against SARS-CoV-2 entry.